# Study of FCN-098 in Patients With Advanced Solid Tumor

> **NCT05212987** · PHASE1 · UNKNOWN · sponsor: **Fochon Pharmaceuticals, Ltd.** · enrollment: 43 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** FCN-098

## Key facts

- **NCT ID:** NCT05212987
- **Lead sponsor:** Fochon Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-31
- **Primary completion:** 2024-05-08
- **Final completion:** 2024-10-12
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05212987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05212987, "Study of FCN-098 in Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05212987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*